| A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma (NCT05249101) | CG Pharmaceuticals, Inc | 2022-08-15 |
| A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects (NCT05380427) | Cutia Therapeutics（Wuxi）Co.,Ltd | 2022-08-15 |
| A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors (NCT05377996) | Day One Biopharmaceuticals, Inc. | 2022-08-15 |
| cePolyTregs in Islet Transplantation (NCT05349591) | University of Alberta | 2022-08-15 |
| Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer (NCT05416775) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-08-15 |
| A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors (NCT05351502) | Beyond Air Inc. | 2022-08-14 |
| A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine (NCT06607380) | Zhuhai Trinomab Pharmaceutical Co., Ltd. | 2022-08-13 |
| A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001） (NCT05357651) | L & L Bio Co., Ltd., Ningbo, China | 2022-08-12 |
| Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old (NCT05477186) | GlaxoSmithKline | 2022-08-12 |
| AOH1996 for the Treatment of Refractory Solid Tumors (NCT05227326) | City of Hope Medical Center | 2022-08-12 |
| Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease (NCT05560607) | AstraZeneca | 2022-08-12 |
| Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications (NCT05104723) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-08-12 |
| Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping (NCT05524883) | Dyne Therapeutics | 2022-08-12 |
| A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling (NCT05492734) | Edgewise Therapeutics, Inc. | 2022-08-12 |
| A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma (NCT05421663) | Janssen Research & Development, LLC | 2022-08-12 |
| Food Effect Study of Linerixibat Tablets in Healthy Adult Participants (NCT05435170) | GlaxoSmithKline | 2022-08-11 |
| A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis (NCT05486208) | Eli Lilly and Company | 2022-08-11 |
| A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men (NCT05498610) | Novo Nordisk A/S | 2022-08-11 |
| A Study of LY3873862 in Healthy Participants (NCT05492201) | Eli Lilly and Company | 2022-08-11 |
| Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study (NCT05392946) | Mayo Clinic | 2022-08-11 |
| Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan (NCT05194111) | Virginia Commonwealth University | 2022-08-11 |
| Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe (NCT05405985) | Galderma R&D | 2022-08-11 |
| A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor (NCT05372367) | Boehringer Ingelheim | 2022-08-11 |
| Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer (NCT05580445) | Shouyao Holdings (Beijing) Co. LTD | 2022-08-11 |
| A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors (NCT05470348) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-08-11 |
| Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) (NCT05431270) | Phanes Therapeutics | 2022-08-11 |
| A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight (NCT05515432) | Bayer | 2022-08-11 |
| A Study to Assess the Relative Bioavailability and Safety of Different Formulations of AZD4831 in Fasted State in Healthy Volunteers. (NCT05457270) | AstraZeneca | 2022-08-11 |
| Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects (NCT06135363) | Guangzhou JOYO Pharma Co., Ltd | 2022-08-11 |
| A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis (NCT05437419) | Teijin America, Inc. | 2022-08-10 |
| Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation (NCT05435846) | Collin Blakely | 2022-08-10 |
| HPV16 E6 TCR T Cells for Cervical Carcinoma (NCT05357027) | TCRCure Biopharma Ltd. | 2022-08-10 |
| Food Effect Study of VER-01 in Healthy Volunteers (NCT04930796) | Vertanical GmbH | 2022-08-10 |
| A Study of IBI311 in Healthy Volunteers (NCT05480579) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-08-10 |
| A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL) (NCT05192486) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-08-10 |
| To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants. (NCT05065463) | AstraZeneca | 2022-08-10 |
| A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants (NCT05363215) | Shionogi | 2022-08-10 |
| Assessing Ketorolac (Toradol) at Oocyte Retrieval (NCT06026553) | Shady Grove Fertility Reproductive Science Center | 2022-08-10 |
| An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT05577611) | Zhongnan Hospital | 2022-08-10 |
| Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects (NCT05476094) | AMIpharm Co., Ltd. | 2022-08-10 |
| Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer (NCT05522738) | Chinese PLA General Hospital | 2022-08-10 |
| A Study of HR19024 in Subjects With Advanced Solid Tumor (NCT05463432) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2022-08-10 |
| A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024) (NCT05468697) | Merck Sharp & Dohme LLC | 2022-08-10 |
| Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study. (NCT05215743) | University of Chile | 2022-08-09 |
| Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee (NCT05419856) | 4Moving Biotech | 2022-08-09 |
| A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (NCT05446740) | GlaxoSmithKline | 2022-08-09 |
| Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants (NCT05324982) | University of Maryland, Baltimore | 2022-08-09 |
| Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma (NCT05451407) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-08-09 |
| A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma (NCT05299424) | Keymed Biosciences Co.Ltd | 2022-08-09 |
| A Study to Evaluate Effects of KN056 in Healthy Participants (NCT05385575) | Suzhou Alphamab Co., Ltd. | 2022-08-09 |
| Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) (NCT05169957) | University of Michigan Rogel Cancer Center | 2022-08-09 |
| A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid Tumors (NCT05461768) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-08-09 |
| A Study of ANX009 in Adult Participants With Lupus Nephritis (NCT05780515) | Annexon, Inc. | 2022-08-09 |
| Study of RP-6306 With FOLFIRI in Advanced Solid Tumors (NCT05147350) | Debiopharm International SA | 2022-08-09 |
| FOLFIRINOX + NIS793 in Pancreatic Cancer (NCT05417386) | Colin D. Weekes, M.D., PhD | 2022-08-09 |
| Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer (NCT05034627) | OHSU Knight Cancer Institute | 2022-08-09 |
| Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008) (NCT05450198) | Merck Sharp & Dohme LLC | 2022-08-08 |
| Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis (NCT05333471) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-08-08 |
| Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression (NCT05472857) | Suzhou Immunofoco Biotechnology Co., Ltd | 2022-08-08 |
| Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers (NCT05428150) | Excalibur Pharmaceuticals, Inc. | 2022-08-08 |
| Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma (NCT05236036) | Northwestern University | 2022-08-08 |
| A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers (NCT05738993) | Biocad | 2022-08-08 |
| Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT05533203) | Shanghai Humantech Biotechnology Co. Ltd | 2022-08-08 |
| A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers (NCT05874167) | Dong Wha Pharmaceutical Co. Ltd. | 2022-08-08 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067 (NCT05306132) | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 2022-08-08 |
| Safety,Tolerability,and Pharmacokinetics Profiles of GB001 Recombinant Peptide Spray in Healthy Subjects (NCT05125211) | Zhejiang Echon Biopharm Limited | 2022-08-08 |
| Study of KBA1412 in Participants With Advanced Solid Malignant Tumors (NCT05501821) | Kling Biotherapeutics B.V. | 2022-08-08 |
| Study to Evaluate IMG-004 in Healthy Participants (NCT05349097) | Inmagene LLC | 2022-08-08 |
| A Phase I Study of SHEN26 Capsule in Healthy Participants (NCT05504746) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2022-08-08 |
| A Study of LY3537021 in Healthy Participants (NCT05444569) | Eli Lilly and Company | 2022-08-08 |
| Treg Immunotherapy in Crohn's Disease (NCT03185000) | King's College London | 2022-08-08 |
| Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV) (NCT06067191) | Pfizer | 2022-08-08 |
| Drug Interaction Study of ASC42 With Atorvastatin (NCT05464628) | Gannex Pharma Co., Ltd. | 2022-08-08 |
| A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection (NCT05414981) | Assembly Biosciences | 2022-08-07 |
| Effect of Red Ginseng Extract on Changes in Indicators of Immune Function in Vietnamese Healthy Volunteers (NCT05480774) | Centre of Clinical Pharmacology, Hanoi Medical University | 2022-08-06 |
| Human Mass Balance and Biotransformation Study of [14C]Afuresertib (NCT05489744) | Laekna Limited | 2022-08-06 |
| A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors. (NCT05338957) | Shanghai Miracogen Inc. | 2022-08-05 |
| Study of Radiolabeled Revumenib in Adults With Acute Leukemia (NCT05406817) | Syndax Pharmaceuticals | 2022-08-05 |
| A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female Participants (NCT05471817) | Bayer | 2022-08-05 |
| A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT05416749) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-08-05 |
| A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults (NCT04844775) | ANRS, Emerging Infectious Diseases | 2022-08-05 |
| A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05028751) | Kronos Bio | 2022-08-05 |
| A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment (NCT05497297) | Haisco Pharmaceutical Group Co., Ltd. | 2022-08-04 |
| Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors (NCT05393986) | Peking University | 2022-08-04 |
| Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) (NCT05464030) | EMD Serono Research & Development Institute, Inc. | 2022-08-04 |
| A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT05456724) | Theratocular Biotek Co. | 2022-08-04 |
| Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation (NCT06809712) | He Huang | 2022-08-04 |
| A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects (NCT05460364) | Boryung Pharmaceutical Co., Ltd | 2022-08-04 |
| Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation (NCT06809699) | He Huang | 2022-08-04 |
| A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus (NCT05411016) | Kyowa Kirin Co., Ltd. | 2022-08-03 |
| First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (NCT05489237) | IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 2022-08-03 |
| A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas (NCT05463263) | Step Pharma, SAS | 2022-08-03 |
| Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma (NCT05487495) | Beijing Boren Hospital | 2022-08-03 |
| Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer (NCT06732531) | Zhuhai Beihai Biotech Co., Ltd | 2022-08-03 |
| Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis (NCT04847453) | National Cancer Institute (NCI) | 2022-08-03 |
| A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children (NCT05197075) | Janssen Research & Development, LLC | 2022-08-03 |
| A Phase 1/2 Study of BA3071 in Patients With Solid Tumors (NCT05180799) | BioAtla, Inc. | 2022-08-03 |
| A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation (NCT05410145) | D3 Bio (Wuxi) Co., Ltd | 2022-08-03 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated (NCT05469646) | Boehringer Ingelheim | 2022-08-03 |
| A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males (NCT05396235) | Tanabe Pharma Corporation | 2022-08-03 |